New data suggest that incidence and prevalence of inflammatory bowel diseases [IBD] are
still increasing worldwide, and approximately 0.2% of the European population suffer from …

The incidence of inflammatory bowel diseases (IBD) in East has risen over the past decade
to become a global disease. The increasing number of studies on the incidence and course …

Methods This document presents the official recommendations of the AGA on the medical
management of moderate to severe luminal and fistulizing CD in adults. This guideline …

The cost of caring for patients with inflammatory bowel disease (IBD) continues to increase
worldwide. The cause is not only a steady increase in the prevalence of Crohn's disease …

Summary Background The Crohn's disease exclusion diet (CDED) with partial enteral
nutrition is effective for induction of remission in children with mild-to-moderate Crohn's …

Inflammatory bowel disease (IBD), which comprises Crohn's disease and ulcerative colitis, is
an idiopathic inflammatory condition of the gastrointestinal tract. The incidence and …

Inflammatory bowel disease is a progressive and debilitating condition. Early and effective
treatment utilizing a treat to target approach is key in improving patient outcomes. Therefore …

Background & Aims We investigated the effects of inducing deep remission in patients with
early Crohn's disease (CD). Methods We collected follow-up data from 122 patients (mean …

Outcomes for patients starting a new treatment for inflammatory bowel disease are
characterized by uncertainty of treatment response. Although it is natural to hope that new …

Summary Background The LIR! C trial showed that laparoscopic ileocaecal resection is a
cost-effective treatment that has similar quality-of-life outcomes to treatment with infliximab …